M.YuanZ.ShettyV.JenkinsS.et al
Properly controlled trials with structural and symptomatic outcome measures would establish whether BPC-157 provides disease-modifying effects or primarily symptomatic relief in joint disorders
[viii] Marso S, Daniels G, Bown-Frandsen K, et.al., Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes, N Engl J Med 2016;375:311-322, DOI: 10.1056/NEJMoa1603827 [ix] Bowe, B., Xie, Y
Supplies Needed Plan based on an 816 week daily protocol with phased dosing (averaging ~700 mcg/day over the cycle)
BPC-157 works by supporting biological repair processes, which take time
Saliva also contributes to the dental pellicle a thin, protective layer that the saliva forms on the surface of the teeth